ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors To Secure Counsel Before Important Deadline In Securities Class Action - RARE
Latest News and Headlines
(MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Feb. 15, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announ...
News